D
Design Therapeutics, Inc. (DSGN)
NMS – Real Time Price. Currency in USD
15.79
+0.18 (1.15%)
At close: May 12, 2026, 4:00 PM EDT
15.79
0.00 (0.00%)
After-hours: May 12, 2026, 7:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
15.79
+0.18 (1.15%)
At close: May 12, 2026, 4:00 PM EDT
15.79
0.00 (0.00%)
After-hours: May 12, 2026, 7:49 PM EDT
Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. The company was incorporated in 2017 and is headquartered in Carlsbad, California.
| Name | Position |
|---|---|
| Dr. Aseem Z. Ansari Ph.D. | Co-Founder & Scientific Advisor |
| Dr. Chengzhi Zhang Ph.D. | Chief Chemist |
| Dr. Chris M. Storgard M.D. | Chief Medical Officer |
| Dr. Sean Jeffries Ph.D. | Chief Operating Officer |
| Dr. Tadimeti S. Rao Ph.D. | Chief Scientific Officer |
| Mr. Doane Chilcoat Ph.D. | Chief Technology Officer |
| Mr. Jim Kerr | Chief of Manufacturing & Product Development |
| Mr. Mustapha Parekh | General Counsel |
| Mr. Pratik Shah Ph.D. | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson |
| Ms. Julie D. Burgess CPA | Chief Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-28 | 8-K | dsgn-20260428.htm |
| 2026-04-28 | 10-Q | dsgn-20260331.htm |
| 2026-04-23 | DEFA14A | dsgn-defa14a-2026.htm |
| 2026-04-01 | 8-K | dsgn-20260331.htm |
| 2026-03-09 | 8-K | dsgn-20260309.htm |
| 2026-01-30 | 8-K | d14213d8k.htm |
| 2025-11-05 | 8-K | dsgn-20251105.htm |
| 2025-11-05 | 10-Q | dsgn-20250930.htm |
| 2025-09-10 | 8-K | dsgn-20250909.htm |
| 2025-08-07 | 10-Q | dsgn-20250630.htm |